No Data
No Data
HK Stocks Unusual Movement | ZhIyun Health (09955) rose nearly 10% during trading hours. The Company introduced injectable solution of Yiluo prostaglandin, which expected to fill the gap in the domestic market.
Zhiyun Health (09955) rose nearly 10% in intraday trading. As of the time of publication, it rose 4.05%, to HKD 1.8, with a turnover of HKD 8.1097 million.
It's Down 26% But ClouDr Group Limited (HKG:9955) Could Be Riskier Than It Looks
ClouDr Group Shifts to Electronic Shareholder Updates
The market cap of the two cities evaporated by over 10 billion yuan. What happened to Remegen (09955, 688331.SH)?
Both industry-level and company-level bullish news seems to have no effect on Remegen (09955, 688331.SH). From the industry perspective, the recently released "Implementation Plan for Supporting the Development of Innovative Drugs throughout the Whole Industry Chain" proposes to strengthen policy guarantees throughout the whole industry chain, coordinate and utilize policies such as price management, medical insurance payment, commercial insurance, pharmaceutical procurement and use, investment and financing, optimize the evaluation and approval process and medical institution assessment mechanism, and jointly promote the breakthrough and development of innovative drugs; mobilize resources for scientific and technological innovation in all aspects, strengthen basic research in new drug development, and consolidate the foundation of China's innovative drug development. So far, Beijing, Guangzhou, Zhuhai and other places have successively issued
Under the carbon dual target, how does Health Park (9955.HK) practice esg?
With the increasing global focus on sustainable development, the ESG (Environmental, Social, and Governance) concept is gradually becoming mainstream. It emphasizes that while pursuing financial performance, companies must pay attention to their impact on the environment, society, and corporate governance. By quantifying, comparing, and continuously improving ESG performance, companies can better fulfill their social responsibilities and achieve long-term sustainable development. So, how does ESG affect the development of companies in the medical and health field? What is the future development trend? Recently, at the "2024 Grontmid-term Strategy Summit" held by Grontmeg, Ms. Xu Lili, the CFO of Zhiyun Health, gave a speech on the topic of "
ClouDr Group to Sell Blood Circulation Drug in China
No Data